Published in World J Gastroenterol on February 28, 2013
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring) (2013) 0.93
The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol (2016) 0.93
Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr (2015) 0.90
Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol (2014) 0.89
Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm (2014) 0.86
Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol (2014) 0.83
β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice. PLoS One (2014) 0.82
Short term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout mice. PLoS One (2014) 0.81
Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. FEBS Open Bio (2014) 0.80
Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World J Gastroenterol (2015) 0.79
Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha. Stem Cells Dev (2016) 0.79
Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiol Rep (2015) 0.79
The Role of Iron and Iron Overload in Chronic Liver Disease. Med Sci Monit (2016) 0.78
Aging Increases Susceptibility to High Fat Diet-Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. Oxid Med Cell Longev (2016) 0.78
Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study. Middle East J Dig Dis (2014) 0.78
Does vitamin C deficiency promote fatty liver disease development? Nutrients (2014) 0.78
CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress. Am J Physiol Endocrinol Metab (2017) 0.77
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J Hepatol (2016) 0.77
Modulation of IKKβ/NF-κB and TGF-β1/Smad via Fuzheng Huayu recipe involves in prevention of nutritional steatohepatitis and fibrosis in mice. Iran J Basic Med Sci (2015) 0.77
Pediatric non-alcoholic steatohepatitis: the first report on the ultrastructure of hepatocyte mitochondria. World J Gastroenterol (2014) 0.77
Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice. PLoS One (2013) 0.76
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emerging Role of Lipin-1. Curr Mol Pharmacol (2015) 0.76
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World J Hepatol (2015) 0.76
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight (2016) 0.76
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.76
Endogenous catalase delays high-fat diet-induced liver injury in mice. Korean J Physiol Pharmacol (2017) 0.75
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury. Front Pharmacol (2017) 0.75
Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment. Sci Rep (2016) 0.75
Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol (2016) 0.75
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World J Gastroenterol (2015) 0.75
The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Nutrients (2015) 0.75
Comprehensive Transcriptome Analyses of the Fructose-Fed Syrian Golden Hamster Liver Provides Novel Insights into Lipid Metabolism. PLoS One (2016) 0.75
Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. Free Radic Biol Med (2017) 0.75
THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL. Arq Bras Cir Dig (2017) 0.75
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice. Sci Rep (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (1998) 18.23
Liver fibrosis. J Clin Invest (2005) 17.27
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science (2003) 16.80
Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet (1999) 14.96
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest (2002) 4.96
Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics (2004) 4.09
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2003) 4.05
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (1999) 3.99
Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis (2007) 3.75
Liver fibrosis in overweight patients. Gastroenterology (2000) 3.56
The epidemic of obesity. J Clin Endocrinol Metab (2004) 3.53
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 3.23
Model of nonalcoholic steatohepatitis. Am J Clin Nutr (2004) 3.13
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 3.11
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology (2004) 2.41
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology (2003) 2.38
Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? Biomark Med (2010) 2.05
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology (2002) 2.02
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology (2000) 1.96
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. J Biol Chem (2001) 1.85
Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol (2008) 1.73
Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab (2004) 1.70
Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet (1993) 1.69
Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci (2003) 1.64
NASH: a mitochondrial disease. J Hepatol (2005) 1.45
Secretome proteomics for discovery of cancer biomarkers. J Proteomics (2010) 1.44
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl (2001) 1.38
Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) (2006) 1.37
Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res (2004) 1.37
Proteome analysis of rat hepatic stellate cells. Hepatology (2000) 1.34
Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis (2004) 1.33
Is liver fibrosis reversible? N Engl J Med (2001) 1.26
Lipid metabolism in hepatic steatosis. Clin Liver Dis (2004) 1.22
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol (1999) 1.21
CYP2E1: from ASH to NASH. Hepatol Res (2004) 1.19
Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology (2003) 1.19
Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol Res (2005) 1.08
Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology (2008) 1.02
Mallory-Denk Bodies in chronic hepatitis. World J Gastroenterol (2011) 0.96
Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2000) 0.94
Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Rev Proteomics (2005) 0.93
Hepatotoxicity of fast food? Gut (2008) 0.91
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol (2011) 0.90
The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol (2003) 0.88
Hyperinsulinemia in nondiabetic, both obese and nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2002) 0.88
Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests. J Hepatol (1991) 0.85
Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol (1994) 0.84
Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Rev Proteomics (2009) 0.84
Genomics and complex liver disease: Challenges and opportunities. Hepatology (2006) 0.84
Leptin in nonalcoholic fatty liver disease. Ann Hepatol (2008) 0.84
Time course of collagen peak in bile duct-ligated rats. BMC Gastroenterol (2011) 0.83
Applying genomics to the study of complex disease. Semin Liver Dis (2007) 0.83
Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis. World J Gastroenterol (2010) 0.83
Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol Belg (2007) 0.81
Arteriovenous malformation of scrotum: a case report. J Urol (1992) 0.81
Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity. Br J Nutr (1999) 0.80
Reliability of caspase activity as a biomarker of hepatic apoptosis in nonalcoholic fatty liver disease. Biomark Med (2011) 0.80
Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon. Liver (1994) 0.77
Fructose as a key player in the development of fatty liver disease. World J Gastroenterol (2013) 1.26
The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients. J Vasc Surg (2005) 1.17
Mallory-Denk Bodies in chronic hepatitis. World J Gastroenterol (2011) 0.96
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. World J Gastroenterol (2011) 0.90
Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions. Clin Endosc (2013) 0.83
Reproducibility of mini-BAL culture results using 10 ml or 20 ml instilled fluid. Intensive Care Med (2003) 0.83
Anesthesia of a patient with cured myasthenia gravis. Anesth Analg (2003) 0.81
Reduction of pain on injection of propofol: a comparison of fentanyl with remifentanil. Anesth Analg (2002) 0.80
Endosonography and elastography in the diagnosis of esophageal tuberculosis. Turk J Gastroenterol (2013) 0.76
Preventive role of gallic acid on alcohol dependent and cysteine protease-mediated pancreas injury. Mol Biol Rep (2012) 0.76
Smoking and postoperative analgesia. Ann Pharmacother (2005) 0.75
Postoperative sore throat: effect of lidocaine jelly and pomade on endotracheal intubation. J Clin Anesth (2004) 0.75
Vater's papillary stenosis in a child with abdominal pain. Pediatr Int (2006) 0.75
Patchy spinal anesthesia. Anesth Analg (2006) 0.75
The effect of Trifolium, Raphanus, and Cistus pollen grains on some blood parameters and mesentery mast cells. Z Naturforsch C (2006) 0.75
Isolated transient diplopia and nystagmus after spinal anesthesia. J Anesth (2013) 0.75
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C. Turk J Gastroenterol (2014) 0.75